Gene · 23049
Papers2,633
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 2,633
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Aeromonas dhakensis: Clinical Isolates with High Carbapenem Resistance. | Pathogens | 2022 | 35894056 | PubTator, text mining | PubMed |
| Succinate Dehydrogenase, Succinate, and Superoxides: A Genetic, Epigenetic, Metabolic, Environmental Explosive Crossroad. | Biomedicines | 2022 | 35892689 | PubTator, text mining | PubMed |
| Development of a Mucoadhesive Vehicle Based on Lyophilized Liposomes for Drug Delivery through the Sublingual Mucosa. | Pharmaceutics | 2022 | 35890395 | PubTator, text mining | PubMed |
| Impact of Antibiotics as Waste, Physical, Chemical, and Enzymatical Degradation: Use of Laccases. | Molecules | 2022 | 35889311 | PubTator, text mining | PubMed |
| Viral Encoded miRNAs in Tumorigenesis: Theranostic Opportunities in Precision Oncology. | Microorganisms | 2022 | 35889167 | PubTator, text mining | PubMed |
| Whole-Genome Sequence of Multidrug-Resistant Methicillin-Resistant Staphylococcusepidermidis Carrying Biofilm-Associated Genes and a Unique Composite of SCCmec. | Antibiotics (Basel) | 2022 | 35884115 | PubTator, text mining | PubMed |
| The triple oxygen isotope composition of marine sulfate and 130 million years of microbial control. | Proc Natl Acad Sci U S A | 2022 | 35881806 | PubTator, text mining | PubMed |
| Advanced Squamous Cell Carcinomas of the Pelvic and Perineal Region: A Comprehensive Genomic Profiling Study. | Oncologist | 2022 | 35881043 | PubTator, text mining | PubMed |
| Isolation of functional ligninolytic Bacillus aryabhattai from paper mill sludge and its lignin degradation potential. | Biotechnol Rep (Amst) | 2022 | 35880093 | PubTator, text mining | PubMed |
| Synaptic components are required for glioblastoma progression in Drosophila. | PLoS Genet | 2022 | 35877760 | PubTator, text mining | PubMed |
| Bioactivation and reactivity research advances - 2021 year in review. | Drug Metab Rev | 2022 | 35876116 | PubTator, text mining | PubMed |
| Curcuminoids as Modulators of EMT in Invasive Cancers: A Review of Molecular Targets With the Contribution of Malignant Mesothelioma Studies. | Front Pharmacol | 2022 | 35873564 | PubTator, text mining | PubMed |
| Enzymatic Active Release of Violacein Present in Nanostructured Lipid Carrier by Lipase Encapsulated in 3D-Bioprinted Chitosan-Hydroxypropyl Methylcellulose Matrix With Anticancer Activity. | Front Chem | 2022 | 35873038 | PubTator, text mining | PubMed |
| Golgi scaffold protein PAQR3 as a candidate suppressor of gastric cardia adenocarcinoma via regulating TGF-β/Smad pathway. | J Clin Lab Anal | 2022 | 35870178 | PubTator, text mining | PubMed |
| Neurocomputational mechanisms of confidence in self and others. | Nat Commun | 2022 | 35869044 | PubTator, text mining | PubMed |
| DDX24 promotes metastasis by regulating RPL5 in non-small cell lung cancer. | Cancer Med | 2022 | 35864588 | PubTator, text mining | PubMed |
| Comprehensive profiling and characterization of cellular microRNAs in response to coxsackievirus A10 infection in bronchial epithelial cells. | Virol J | 2022 | 35864512 | PubTator, text mining | PubMed |
| Engineered exosome-mediated delivery of circDIDO1 inhibits gastric cancer progression via regulation of MiR-1307-3p/SOCS2 Axis. | J Transl Med | 2022 | 35864511 | PubTator, text mining | PubMed |
| Effectiveness and Safety of Antithrombotic Medication in Patients With Atrial Fibrillation and Intracranial Hemorrhage: Systematic Review and Meta-Analysis. | Stroke | 2022 | 35862238 | PubTator, text mining | PubMed |
| Emerging Mechanisms and Targeted Therapy of Ferroptosis in Neurological Diseases and Neuro-oncology. | Int J Biol Sci | 2022 | 35844784 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23049/papers?page=28